Back to Archived Journals » Comparative Effectiveness Research » Volume 8
Corrigendum
Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,335 | Dovepress* | 5,335+ | 654 | 5,989 | |
Totals | 5,335 | 654 | 5,989 | ||
*Since 24 January 2018 |
View citations on Google Scholar